Bioaminex does not sell products directly. Everything begins with lab work and a licensed physician. Please confirm you understand:
Peptide therapies may involve compounds that are prescription-only or investigational. Nothing here should be used without physician supervision and appropriate laboratory monitoring.
Straight, research-grounded explainers — including approval status, mechanism, the state of the evidence, and why supervision matters.
An FDA-approved dual-incretin for type 2 diabetes and weight management. How it works, who it's studied in, and why it's prescription-only.
Read the explainer →The GLP-1 agonist that started this era of medical weight management, with robust trial evidence and real contraindications.
Read the explainer →An investigational triple agonist in Phase 3 trials with impressive early data, but not yet approved.
Read the explainer → RecoveryA high-interest recovery peptide with extensive animal data but limited rigorous human evidence.
Read the explainer → RecoveryFrequently discussed in recovery stacks, with a preclinical-heavy evidence base and unresolved safety questions.
Read the explainer → Growth axisAn FDA-approved GHRH analog with a specific indication and meaningful monitoring requirements.
Read the explainer → Growth axisPreviously FDA-approved, now compounded-only for business-discontinuation reasons, not a safety withdrawal.
Read the explainer → Growth axisA more selective GH secretagogue often paired with CJC-1295, with limited long-term outcomes data.
Read the explainer → Growth axisA long-acting GHRH analog with FDA-flagged cardiovascular safety concerns worth discussing directly.
Read the explainer → LongevityEssential cell biology with a major evidence gap between anti-aging marketing claims and IV outcomes data.
Read the explainer → LongevityA core antioxidant with stronger biological plausibility than high-quality trial support for many injectable claims.
Read the explainer → LongevityA compelling research signal in metabolism and exercise pathways, still early and not proven in large human trials.
Read the explainer → LongevityA long Russian research history centered on telomerase claims, with limited independent Western replication.
Read the explainer → LongevityA low-risk, evidence-backed injectable when deficiency is present; less compelling as a generic energy booster.
Read the explainer → Skin & tissueStrongest human evidence is topical skin use; injectable systemic claims remain much less established.
Read the explainer → Sexual healthAn FDA-approved option for HSDD with meaningful efficacy data and a side-effect profile that requires frank counseling.
Read the explainer → ImmuneExtensive international trial and approval history, but no FDA approval in the US pathway.
Read the explainer → CognitiveApproved and used in Russia for anxiety, with human data that has not yet been independently replicated in Western trials.
Read the explainer → CognitiveThree decades of Russian neurological use, without FDA review or modern Western-standard replication.
Read the explainer →Education is step one. If you want to know whether any of this is right for you, that's a conversation with a licensed provider — starting with your labs.
Start your consultation